- mab: Adintrevimab
  synonyms: ADG20;ADG-2
  num_ref_name: 28
  num_fold: 223
  avail: Phase 3
  target: RBD
  class: RBD Core Cluster I
  pdb: 7U2D
  institute: Adagio Therapeutics
  origin: CP
- mab: C144
  synonyms: BMS-986413
  num_ref_name: 14
  num_fold: 156
  avail: Phase 2/3
  target: RBD
  class: RBM Class III
  pdb: 7K90
  institute: Rockefeller University
  origin: CP
- mab: C135
  synonyms: BMS-986414
  num_ref_name: 10
  num_fold: 96
  avail: Phase 2/3
  target: RBD
  class: RBD Core Cluster I
  pdb: 7K8Z
  institute: Rockefeller University
  origin: CP
- mab: DXP-604
  synonyms: BD-604
  num_ref_name: 5
  num_fold: 34
  avail: Phase 1
  target: RBD
  class: RBM Class I
  pdb: 7CH4
  institute: Singlomics Biopharmaceuticals
  origin: CP
- mab: ABBV-47D11
  synonyms: 47D11
  num_ref_name: 3
  num_fold: 19
  avail: Phase 1
  target: RBD
  class: RBD Core Cluster I
  pdb: 7AKD
  institute: Utrecht University & AbbVie
  origin: Transgenic mice
- mab: Regdanvimab
  synonyms: CT-P59
  num_ref_name: 20
  num_fold: 135
  avail: KR-Approved
  target: RBD
  class: RBM Class I
  pdb: 7CM4
  institute: Celltrion
  origin: Phage display library
- mab: Imdevimab
  synonyms: REGN10987
  num_ref_name: 93
  num_fold: 793
  avail: EUA
  target: RBD
  class: RBD Core Cluster I
  pdb: 6XDG
  institute: Regeneron
  origin: Transgenic mice
- mab: Casirivimab
  synonyms: REGN10933
  num_ref_name: 91
  num_fold: 751
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 6XDG
  institute: Regeneron
  origin: Transgenic mice
- mab: Sotrovimab
  synonyms: GSK4182136;S309;Vir-7831;Xevudy
  num_ref_name: 73
  num_fold: 729
  avail: EUA
  target: RBD
  class: RBD Core Cluster I
  pdb: 6WPS
  institute: Vir Biotechnol
  origin: SARS-CoV CP
- mab: Etesevimab
  synonyms: CB6;Shi-CB6;JS-016;LY-CoV016;LY3832479
  num_ref_name: 73
  num_fold: 685
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 7C01
  institute: Eli Lilly
  origin: CP
- mab: Bamlanivimab
  synonyms: LY-CoV555;LY3819253
  num_ref_name: 69
  num_fold: 551
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7KMG
  institute: Eli Lilly
  origin: CP
- mab: Bebtelovimab
  synonyms: LY-CoV1404;LY3853113
  num_ref_name: 24
  num_fold: 438
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7MMO
  institute: Eli Lilly
  origin: CP
- mab: Cilgavimab
  synonyms: COV2-2130;AZD1061
  num_ref_name: 58
  num_fold: 402
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7L7E
  institute: AstraZeneca
  origin: CP
- mab: Tixagevimab
  synonyms: COV2-2196;AZD8895
  num_ref_name: 57
  num_fold: 392
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 7L7E
  institute: AstraZeneca
  origin: CP
- mab: Amubarvimab
  synonyms: BRII-196;P2C-1F11
  num_ref_name: 21
  num_fold: 337
  avail: CN-Approved
  target: RBD
  class: RBM Class I
  pdb: 7CDI
  institute: Brii Biosciences
  origin: ''
- mab: Romlusevimab
  synonyms: BRII-198;P2B-1G5
  num_ref_name: 13
  num_fold: 170
  avail: CN-Approved
  target: RBD
  class: RBD Core Cluster II
  pdb: ''
  institute: Brii Biosciences
  origin: ''
